Latest Regulatory News

Identitii Limited has announced a pro rata non-renounceable rights issue to raise approximately $2.88 million, partially underwritten by Beauvais Capital Pty Ltd. The funds will support the development and commercialisation of its BNDRY platform amid ongoing patent litigation risks.

Macquarie Group Limited has updated details for its interim dividend, confirming a fully franked payout of AUD 2.80 per share and setting the Dividend Reinvestment Plan price at AUD 195.34.

IPB Petroleum has signed a binding terms sheet to acquire a significant acreage position in Alaska’s National Petroleum Reserve, including the Umiat oil field, while raising $1.27 million to fund exploration and development studies.

Anteris Technologies has secured regulatory green lights for its pivotal PARADIGM trial and raised $25.2 million in capital, advancing its innovative DurAVR® transcatheter heart valve towards commercialisation.

The Takeovers Panel has directed Emu NL and its former directors to cover a combined $41,712 in costs incurred by Wayburn Holdings during takeover proceedings, underscoring ongoing regulatory scrutiny.

Pro Medicus has disclosed a contained data breach involving unauthorized access to a single employee email inbox, with limited exposure of personal information from around 100 current and former employees.

Volt Resources has initiated a Definitive Feasibility Study for its Alabama Graphite Refinery, aiming to produce high purity graphite by mid-2026 and strengthen US critical minerals supply chains.

Chariot Resources has confirmed high-grade lithium mineralisation at its Fonlo and Iganna projects in Nigeria, with assays returning up to 5.96% lithium oxide. The results reinforce the potential for near-term production and resource expansion within its Nigerian lithium portfolio.

Global Lithium Resources has released a Definitive Feasibility Study for its Manna Lithium Project, confirming robust financials and a long mine life in Western Australia. The study sets the stage for a Final Investment Decision in 2026 amid improving lithium market conditions.

InhaleRx has boosted its funding facility by $12.6 million to accelerate clinical trials of SRX-25, a novel oral treatment for Treatment-Resistant Depression. This brings total available capital to $52.3 million, positioning the company for pivotal Phase III studies.

Savannah Goldfields has poured nearly 7kg of doré at its Georgetown Gold Processing Plant, marking steady progress in gold production and setting the stage for upcoming mining at Big Reef and Agate Creek.

St George Mining’s Araxá Project in Brazil gains significant government and community support, highlighting its potential as a world-class rare earths and niobium resource with sustainable mining at its core.